(NASDAQ: WBA) Walgreens Boots Alliance's forecast annual revenue growth rate of 1.11% is forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 1.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.39%.
Walgreens Boots Alliance's revenue in 2025 is $154,580,000,000.On average, 5 Wall Street analysts forecast WBA's revenue for 2025 to be $132,023,460,808,073, with the lowest WBA revenue forecast at $129,168,877,189,911, and the highest WBA revenue forecast at $135,136,525,945,050. On average, 5 Wall Street analysts forecast WBA's revenue for 2026 to be $133,302,349,209,963, with the lowest WBA revenue forecast at $124,298,800,052,023, and the highest WBA revenue forecast at $137,229,451,657,200.
In 2027, WBA is forecast to generate $140,167,635,453,157 in revenue, with the lowest revenue forecast at $139,907,252,297,540 and the highest revenue forecast at $140,428,018,608,775.